NCT02570932View on ClinicalTrials.gov

Administration of Expanded Autologous Adult Bone Marrow Mesenchymal Cells in Established Chronic Spinal Cord Injuries

PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

December 4, 2017

Study Completion Date

December 4, 2017

Conditions
Spinal Cord Injury
Interventions
BIOLOGICAL

Autologous Mesenchymal Bone Marrow Cell

"Suspension in autologous plasma cell of Adult mesenchymal stem cells expanded autologous bone marrow.~Route of administration: Intrathecal in subarachnoid space by lumbar puncture.Total dose of 300 x 106 CME, divided in 3 injections of 100 x 106 CME, with intervals of three months between each administration"

Trial Locations (1)

28222

Hospital Puerta de Hierro, Majadahonda

All Listed Sponsors
lead

Puerta de Hierro University Hospital

OTHER

NCT02570932 - Administration of Expanded Autologous Adult Bone Marrow Mesenchymal Cells in Established Chronic Spinal Cord Injuries | Biotech Hunter | Biotech Hunter